Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19)
Jeffrey D. Jenks, Saima Aslam, Lucy E. Horton, Nancy Law, Ajay Bharti, Cathy Logan, Mahnaz Taremi, Florin Vaida, Michele Ritter, Ajay Bharti, Nancy Law, Kathleen Bordeaux, Claudia Guerrero, Diana Paddock, Joseph Bautista, Claudia Medrano, Sarah Arend, Mackenzie Williams, Marvin Ochoa Vega, C. Montilla
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BetacoronavirusMonoclonal antibodyVirologyDiseaseCoronavirus InfectionsPandemicAdministration (probate law)AntibodyIntensive care medicineImmunologyOutbreakInternal medicineInfectious disease (medical specialty)Political scienceLawCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research